Skip to content

A prospective observational study on systemic treatment for advanced renal cell carcinoma

A prospective observational study on systemic treatment for advanced renal cell carcinoma - Advanced RCC Registry

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000028814
Enrollment
400
Registered
2017-08-25
Start date
2017-08-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced renal cell carcinoma

Interventions

None listed

Sponsors

Department of Urology, Kindai University Faculty of Medicine
Lead Sponsor
Osaka Urology Research Foundation
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients on treatment with systemic therapy with targeted agents

Exclusion criteria

Exclusion criteria: Patients on treatment with systemic therapy with targeted agents as pre-surgical treatment prior to cytoreductive nephrectomy. Patients with cytokine therapy only.

Design outcomes

Primary

MeasureTime frame
Treatment duration for every systemic treatment

Secondary

MeasureTime frame
Objective response Time to response Time to progression Overall survival Adverse event profile

Countries

Japan

Contacts

Public ContactMasahiro Nozawa

Kindai University Faculty of Medicine Urology

nozawa06@med.kindai.ac.jp072-366-0221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026